Twist Bioscience Corp (NASDAQ: TWST) kicked off on Friday, down -3.20% from the previous trading day, before settling in for the closing price of $45.00. Over the past 52 weeks, TWST has traded in a range of $14.42-$60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 60.13%. While this was happening, its average annual earnings per share was recorded 4.32%. With a float of $56.02 million, this company’s outstanding shares have now reached $57.56 million.
The extent of productivity of a business whose workforce counts for 919 workers is very important to gauge. In terms of profitability, gross margin is 40.53%, operating margin of -64.35%, and the pretax margin is -74.48%.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 4.27%, while institutional ownership is 106.41%. The most recent insider transaction that took place on Aug 05 ’24, was worth 28,308. In this transaction an insider of this company sold 709 shares at a rate of $39.93, taking the stock ownership to the 78,996 shares. Before that another transaction happened on Aug 05 ’24, when Company’s President and COO sold 2,885 for $39.93, making the entire transaction worth $115,187. This insider now owns 168,327 shares in total.
Twist Bioscience Corp (TWST) Latest Financial update
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.81 earnings per share (EPS), higher than consensus estimate (set at -0.92) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.32% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Take a look at Twist Bioscience Corp’s (TWST) current performance indicators. Last quarter, stock had a quick ratio of 4.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -2.39 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
The latest stats from [Twist Bioscience Corp, TWST] show that its last 5-days average volume of 0.74 million was inferior to 1.04 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic%D was 47.19%. Additionally, its Average True Range was 3.44.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 48.22%, which indicates a significant increase from 31.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 100.67% in the past 14 days, which was higher than the 77.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $50.45, while its 200-day Moving Average is $37.93. Now, the first resistance to watch is $44.67. This is followed by the second major resistance level at $45.79. The third major resistance level sits at $46.48. If the price goes on to break the first support level at $42.87, it is likely to go to the next support level at $42.18. The third support level lies at $41.06 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
The company with the Market Capitalisation of 2.55 billion has total of 58,226K Shares Outstanding. Its annual sales at the moment are 245,110 K in contrast with the sum of -204,620 K annual income. Company’s last quarter sales were recorded 81,460 K and last quarter income was -85,570 K.
